Perdagangan Raffles Medical - BSLsg CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0182 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.020397% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | -0.001521% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | SGD | ||||||||
Margin | 20% | ||||||||
Bursa efek | Singapore | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Raffles Medical Group Ltd ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 1.2959 |
Open* | 1.3059 |
1-Year Change* | 14.92% |
Day's Range* | 1.3059 - 1.3159 |
52 wk Range | 1.09-1.52 |
Average Volume (10 days) | 1.20M |
Average Volume (3 months) | 31.79M |
Market Cap | 2.50B |
P/E Ratio | 17.29 |
Shares Outstanding | 1.86B |
Revenue | 766.54M |
EPS | 0.08 |
Dividend (Yield %) | 2.85714 |
Beta | 0.79 |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jun 1, 2023 | 1.3159 | 0.0100 | 0.77% | 1.3059 | 1.3258 | 1.3059 |
May 31, 2023 | 1.2959 | -0.0200 | -1.52% | 1.3159 | 1.3258 | 1.2959 |
May 30, 2023 | 1.3258 | 0.0000 | 0.00% | 1.3258 | 1.3258 | 1.3059 |
May 29, 2023 | 1.3159 | -0.0199 | -1.49% | 1.3358 | 1.3358 | 1.3159 |
May 26, 2023 | 1.3358 | -0.0100 | -0.74% | 1.3458 | 1.3458 | 1.3358 |
May 25, 2023 | 1.3458 | 0.0100 | 0.75% | 1.3358 | 1.3458 | 1.3258 |
May 24, 2023 | 1.3458 | -0.0299 | -2.17% | 1.3757 | 1.3757 | 1.3458 |
May 23, 2023 | 1.3757 | 0.0199 | 1.47% | 1.3558 | 1.3757 | 1.3458 |
May 22, 2023 | 1.3458 | 0.0100 | 0.75% | 1.3358 | 1.3558 | 1.3358 |
May 19, 2023 | 1.3458 | -0.0100 | -0.74% | 1.3558 | 1.3558 | 1.3458 |
May 18, 2023 | 1.3657 | 0.0099 | 0.73% | 1.3558 | 1.3657 | 1.3458 |
May 17, 2023 | 1.3358 | -0.0200 | -1.48% | 1.3558 | 1.3657 | 1.3258 |
May 16, 2023 | 1.3657 | -0.0200 | -1.44% | 1.3857 | 1.3857 | 1.3657 |
May 15, 2023 | 1.3757 | 0.0100 | 0.73% | 1.3657 | 1.3857 | 1.3657 |
May 12, 2023 | 1.4056 | -0.0100 | -0.71% | 1.4156 | 1.4156 | 1.4056 |
May 11, 2023 | 1.4156 | 0.0100 | 0.71% | 1.4056 | 1.4156 | 1.4056 |
May 10, 2023 | 1.4056 | -0.0399 | -2.76% | 1.4455 | 1.4455 | 1.4056 |
May 9, 2023 | 1.4455 | 0.0000 | 0.00% | 1.4455 | 1.4455 | 1.4455 |
May 5, 2023 | 1.4555 | 0.0000 | 0.00% | 1.4555 | 1.4555 | 1.4455 |
May 4, 2023 | 1.4555 | 0.0100 | 0.69% | 1.4455 | 1.4555 | 1.4455 |
Raffles Medical Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 766.537 | 723.791 | 568.203 | 522.038 | 489.135 |
Revenue | 766.537 | 723.791 | 568.203 | 522.038 | 489.135 |
Cost of Revenue, Total | 126.556 | 143.27 | 135.775 | 110.969 | 99.518 |
Gross Profit | 639.981 | 580.521 | 432.428 | 411.069 | 389.617 |
Total Operating Expense | 570.691 | 602.485 | 479.761 | 445.87 | 404.9 |
Selling/General/Admin. Expenses, Total | 344.56 | 390.212 | 295.637 | 274.059 | 259.514 |
Depreciation / Amortization | 40.216 | 39.326 | 35.495 | 29.26 | 18.273 |
Other Operating Expenses, Total | 42.147 | 36.147 | 12.854 | 31.582 | 30.99 |
Operating Income | 195.846 | 121.306 | 88.442 | 76.168 | 84.235 |
Interest Income (Expense), Net Non-Operating | -4.142 | -5.722 | -4.003 | -0.244 | -0.101 |
Net Income Before Taxes | 191.704 | 115.584 | 84.439 | 75.924 | 84.134 |
Net Income After Taxes | 143.702 | 83.716 | 64.67 | 60.522 | 70.803 |
Minority Interest | -0.186 | 0.455 | 1.221 | -0.249 | 0.253 |
Net Income Before Extra. Items | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Net Income | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Income Available to Common Excl. Extra. Items | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Income Available to Common Incl. Extra. Items | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Diluted Net Income | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Diluted Weighted Average Shares | 1866.35 | 1876.46 | 1840.37 | 1815.81 | 1788.29 |
Diluted EPS Excluding Extraordinary Items | 0.0769 | 0.04486 | 0.0358 | 0.03319 | 0.03973 |
Dividends per Share - Common Stock Primary Issue | 0.038 | 0.018 | 0.025 | 0.025 | 0.025 |
Diluted Normalized EPS | 0.0843 | 0.04433 | 0.03794 | 0.03326 | 0.04 |
Interest Expense (Income) - Net Operating | -3.395 | ||||
Unusual Expense (Income) | 17.212 | -6.47 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Total revenue | 384.233 | 382.304 | 379.976 | 343.815 | 326.783 |
Revenue | 384.233 | 382.304 | 379.976 | 343.815 | 326.783 |
Cost of Revenue, Total | 65.467 | 61.089 | 72.129 | 71.141 | 75.959 |
Gross Profit | 318.766 | 321.215 | 307.847 | 272.674 | 250.824 |
Total Operating Expense | 274.764 | 295.927 | 314.733 | 287.752 | 262.623 |
Selling/General/Admin. Expenses, Total | 146.85 | 197.71 | 205.197 | 185.015 | 156.41 |
Depreciation / Amortization | 19.59 | 20.626 | 20.846 | 18.48 | 17.91 |
Interest Expense (Income) - Net Operating | |||||
Unusual Expense (Income) | 17.296 | ||||
Other Operating Expenses, Total | 25.561 | 16.502 | 16.561 | 13.116 | 12.344 |
Operating Income | 109.469 | 86.377 | 65.243 | 56.063 | 64.16 |
Interest Income (Expense), Net Non-Operating | -1.248 | -2.894 | -3.25 | -2.472 | -2.182 |
Net Income Before Taxes | 108.221 | 83.483 | 61.993 | 53.591 | 61.978 |
Net Income After Taxes | 83.74 | 59.962 | 44.876 | 38.84 | 48.379 |
Minority Interest | 0.105 | -0.291 | -0.15 | 0.605 | 0.268 |
Net Income Before Extra. Items | 83.845 | 59.671 | 44.726 | 39.445 | 48.647 |
Net Income | 83.845 | 59.671 | 44.726 | 39.445 | 48.647 |
Income Available to Common Excl. Extra. Items | 83.845 | 59.671 | 44.726 | 39.445 | 48.647 |
Income Available to Common Incl. Extra. Items | 83.845 | 59.671 | 44.726 | 39.445 | 48.647 |
Diluted Net Income | 83.845 | 59.671 | 44.726 | 39.445 | 48.647 |
Diluted Weighted Average Shares | 1863.62 | 1869.07 | 1882.52 | 1870.4 | 1851.09 |
Diluted EPS Excluding Extraordinary Items | 0.04499 | 0.03193 | 0.02376 | 0.02109 | 0.02628 |
Dividends per Share - Common Stock Primary Issue | 0.038 | 0 | 0.018 | 0 | 0.02 |
Diluted Normalized EPS | 0.05266 | 0.02963 | 0.02425 | 0.01858 | 0.0269 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 460.257 | 439.099 | 331.13 | 246.006 | 198.525 |
Cash and Short Term Investments | 253.127 | 264.988 | 203.114 | 151.826 | 105.984 |
Cash & Equivalents | |||||
Total Receivables, Net | 194.032 | 160.737 | 113.429 | 83.935 | 83.221 |
Accounts Receivable - Trade, Net | 194.032 | 160.737 | 113.429 | 83.935 | 83.221 |
Total Inventory | 13.098 | 13.374 | 14.587 | 10.245 | 9.32 |
Total Assets | 1497.7 | 1545.29 | 1404.13 | 1284.82 | 1116.29 |
Property/Plant/Equipment, Total - Net | 739.072 | 797.362 | 739.905 | 685.585 | 565.716 |
Property/Plant/Equipment, Total - Gross | 908.471 | 959.927 | 879.784 | 819.76 | 674.788 |
Accumulated Depreciation, Total | -169.399 | -162.565 | -139.879 | -134.175 | -109.072 |
Goodwill, Net | 11.15 | 18.322 | 21.233 | 23.835 | 24.423 |
Intangibles, Net | 9.124 | 13.508 | 12.911 | 13.619 | 12.864 |
Long Term Investments | 273.4 | 274 | 294.6 | 311.16 | 311.16 |
Note Receivable - Long Term | 2.274 | 1.857 | 3.285 | 3.452 | 2.59 |
Other Long Term Assets, Total | 2.425 | 1.138 | 1.07 | 1.165 | 1.011 |
Total Current Liabilities | 325.7 | 416.611 | 279.924 | 218.953 | 186.329 |
Payable/Accrued | 223.771 | 253.568 | 191.382 | 162.53 | 136.789 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 19.326 | 106.54 | 38.736 | 19.301 | 19.307 |
Other Current Liabilities, Total | 82.603 | 56.503 | 49.806 | 37.122 | 30.233 |
Total Liabilities | 482.648 | 584.492 | 505.138 | 443.929 | 315.8 |
Total Long Term Debt | 76.817 | 91.592 | 166.157 | 181.075 | 97.189 |
Long Term Debt | 63.376 | 77.914 | 143.859 | 156.559 | 97.189 |
Deferred Income Tax | 8.303 | 10.147 | 7.746 | 7.014 | 4.765 |
Minority Interest | 15.35 | 15.826 | 15.401 | 15.961 | 16.137 |
Other Liabilities, Total | 56.478 | 50.316 | 35.91 | 20.926 | 11.38 |
Total Equity | 1015.05 | 960.794 | 898.996 | 840.893 | 800.489 |
Common Stock | 432.379 | 426.346 | 420.966 | 393.47 | 365.332 |
Retained Earnings (Accumulated Deficit) | 606.22 | 512.222 | 463.172 | 441.519 | 424.921 |
Unrealized Gain (Loss) | 16.367 | 16.367 | 16.367 | 16.367 | 16.367 |
Other Equity, Total | -13.018 | 9.089 | -1.109 | -10.063 | -6.131 |
Total Liabilities & Shareholders’ Equity | 1497.7 | 1545.29 | 1404.13 | 1284.82 | 1116.29 |
Total Common Shares Outstanding | 1854.55 | 1868.29 | 1864.73 | 1827.94 | 1797.17 |
Cash | 83.159 | 99.152 | 44.753 | 52.108 | 61.406 |
Short Term Investments | 169.968 | 165.836 | 158.361 | 99.718 | 44.578 |
Capital Lease Obligations | 13.441 | 13.678 | 22.298 | 24.516 | |
Treasury Stock - Common | -26.894 | -3.23 | -0.4 | -0.4 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Total Current Assets | 460.257 | 432.309 | 439.099 | 358.517 | 331.13 |
Cash and Short Term Investments | 253.127 | 289.067 | 264.988 | 215.741 | 203.114 |
Cash & Equivalents | 253.127 | 289.067 | 264.988 | 215.741 | 203.114 |
Total Receivables, Net | 194.032 | 130.682 | 160.737 | 128.279 | 113.429 |
Accounts Receivable - Trade, Net | 194.032 | 130.682 | 160.737 | 128.279 | 113.429 |
Total Inventory | 13.098 | 12.56 | 13.374 | 14.497 | 14.587 |
Total Assets | 1497.7 | 1518.86 | 1545.29 | 1455.09 | 1404.13 |
Property/Plant/Equipment, Total - Net | 739.072 | 777.775 | 797.362 | 763.52 | 739.905 |
Intangibles, Net | 9.124 | 12.136 | 31.83 | 35.132 | 34.144 |
Long Term Investments | 273.4 | 274 | 274 | 294.6 | 294.6 |
Note Receivable - Long Term | 2.274 | 3.313 | 1.857 | 2.172 | 3.285 |
Other Long Term Assets, Total | 2.425 | 1.243 | 1.138 | 1.147 | 1.07 |
Total Current Liabilities | 325.7 | 404.253 | 416.611 | 318.25 | 279.924 |
Payable/Accrued | 223.771 | 243.622 | 253.568 | 207.487 | 191.382 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 19.326 | 86.224 | 106.54 | 49.177 | 38.736 |
Other Current Liabilities, Total | 82.603 | 74.407 | 56.503 | 61.586 | 49.806 |
Total Liabilities | 482.648 | 573.114 | 584.492 | 544.256 | 505.138 |
Total Long Term Debt | 76.817 | 89.623 | 91.592 | 162.65 | 166.157 |
Long Term Debt | 63.376 | 77.914 | 77.914 | 145.036 | 143.859 |
Capital Lease Obligations | 13.441 | 11.709 | 13.678 | 17.614 | 22.298 |
Deferred Income Tax | 8.303 | 10.615 | 10.147 | 7.68 | 7.746 |
Minority Interest | 15.35 | 16.093 | 15.826 | 15.358 | 15.401 |
Other Liabilities, Total | 56.478 | 52.53 | 50.316 | 40.318 | 35.91 |
Total Equity | 1015.05 | 945.745 | 960.794 | 910.832 | 898.996 |
Common Stock | 432.379 | 430.777 | 426.346 | 423.176 | 420.966 |
Retained Earnings (Accumulated Deficit) | 606.22 | 521.306 | 512.222 | 466.228 | 463.172 |
Treasury Stock - Common | -26.894 | -26.787 | -3.23 | 0 | -0.4 |
Unrealized Gain (Loss) | 16.367 | 16.367 | 16.367 | 16.367 | 16.367 |
Other Equity, Total | -13.018 | 4.082 | 9.089 | 5.061 | -1.109 |
Total Liabilities & Shareholders’ Equity | 1497.7 | 1518.86 | 1545.29 | 1455.09 | 1404.13 |
Total Common Shares Outstanding | 1854.55 | 1852.44 | 1868.29 | 1867.56 | 1864.73 |
Goodwill, Net | 11.15 | 18.083 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 143.702 | 83.716 | 64.67 | 60.522 | 70.803 |
Cash From Operating Activities | 196.225 | 160.112 | 133.146 | 111.147 | 91.528 |
Cash From Operating Activities | 37.513 | 36.725 | 33.487 | 27.65 | 17.172 |
Amortization | 2.703 | 2.601 | 2.008 | 1.61 | 1.101 |
Non-Cash Items | 74.315 | 44.642 | 34.985 | 15.06 | 12.069 |
Cash Taxes Paid | 29.146 | 21.742 | 9.705 | 12.488 | 12.694 |
Cash Interest Paid | 6.796 | 7.305 | 6.025 | 4.857 | 2.03 |
Changes in Working Capital | -62.008 | -7.572 | -2.004 | 6.305 | -9.617 |
Cash From Investing Activities | -22.832 | -52.199 | -62.189 | -96.871 | -102.656 |
Capital Expenditures | -25.299 | -52.804 | -60.064 | -98.379 | -31.407 |
Other Investing Cash Flow Items, Total | 2.467 | 0.605 | -2.125 | 1.508 | -71.249 |
Cash From Financing Activities | -183.702 | -46.873 | -20.878 | 31.547 | 20.076 |
Financing Cash Flow Items | -6.796 | -7.305 | -6.025 | -4.857 | -2.413 |
Total Cash Dividends Paid | -52.015 | -37.349 | -19.186 | -17.954 | -15.63 |
Issuance (Retirement) of Stock, Net | -18.311 | 2.365 | 0.778 | 0.582 | 0.771 |
Issuance (Retirement) of Debt, Net | -106.58 | -4.584 | 3.555 | 53.776 | 37.348 |
Foreign Exchange Effects | -1.545 | 0.811 | 1.229 | -1.058 | -1.234 |
Net Change in Cash | -11.854 | 61.851 | 51.308 | 44.765 | 7.714 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 143.702 | 59.962 | 83.716 | 38.84 | 64.67 |
Cash From Operating Activities | 196.225 | 134.9 | 160.112 | 83.183 | 133.146 |
Cash From Operating Activities | 37.513 | 19.265 | 36.725 | 17.345 | 33.487 |
Amortization | 2.703 | 1.361 | 2.601 | 1.135 | 2.008 |
Non-Cash Items | 74.315 | 27.966 | 44.642 | 18.355 | 34.985 |
Cash Taxes Paid | 29.146 | 14.588 | 21.742 | 11.505 | 9.705 |
Cash Interest Paid | 6.796 | 3.524 | 7.305 | 3.455 | 6.025 |
Changes in Working Capital | -62.008 | 26.346 | -7.572 | 7.508 | -2.004 |
Cash From Investing Activities | -22.832 | -11.363 | -52.199 | -40.441 | -62.189 |
Capital Expenditures | -25.299 | -11.811 | -52.804 | -40.711 | -60.064 |
Other Investing Cash Flow Items, Total | 2.467 | 0.448 | 0.605 | 0.27 | -2.125 |
Cash From Financing Activities | -183.702 | -99.078 | -46.873 | -30.648 | -20.878 |
Financing Cash Flow Items | -6.796 | -3.524 | -7.305 | -3.455 | -6.025 |
Total Cash Dividends Paid | -52.015 | -52.015 | -37.349 | -37.349 | -19.186 |
Issuance (Retirement) of Stock, Net | -18.311 | -19.126 | 2.365 | 2.504 | 0.778 |
Issuance (Retirement) of Debt, Net | -106.58 | -24.413 | -4.584 | 7.652 | 3.555 |
Foreign Exchange Effects | -1.545 | -0.413 | 0.811 | 0.514 | 1.229 |
Net Change in Cash | -11.854 | 24.046 | 61.851 | 12.608 | 51.308 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Raffles Medical Holdings Pte. Ltd. | Corporation | 38.2051 | 719394504 | 0 | 2022-08-02 | |
Loo (Choon Yong) | Individual Investor | 10.7543 | 202500534 | 353800 | 2022-08-02 | LOW |
Global Alpha Capital Management Ltd. | Investment Advisor | 8.9628 | 168768350 | 19839900 | 2022-11-17 | LOW |
S & D Holdings Pte. Ltd. | Corporation | 3.3356 | 62809182 | 2500 | 2022-10-05 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3827 | 26036315 | 32000 | 2023-04-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8976 | 16901331 | -80493 | 2022-12-31 | LOW |
Tan (Tiang Lee) | Individual Investor | 0.8188 | 15417192 | 98000 | 2022-03-16 | |
Asian Medical Foundation Ltd. | Corporation | 0.767 | 14443321 | 0 | 2022-03-16 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.6513 | 12263100 | -69200 | 2023-04-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.6206 | 11685534 | 106800 | 2023-04-30 | LOW |
Florida State Board of Administration | Pension Fund | 0.5849 | 11014211 | -1268171 | 2022-09-30 | LOW |
Yii (Hee Seng) | Individual Investor | 0.5152 | 9700513 | 0 | 2022-03-16 | |
iFAST Financial Pte. Ltd. | Corporation | 0.2533 | 4769437 | 4769437 | 2022-03-16 | LOW |
Baillie Gifford & Co. | Investment Advisor | 0.2463 | 4636995 | 0 | 2023-01-31 | LOW |
Schroder Investment Management (Singapore) Ltd. | Investment Advisor/Hedge Fund | 0.2426 | 4568152 | 0 | 2022-12-31 | LOW |
Tan (Soo Nan) | Individual Investor | 0.2412 | 4541000 | 5000 | 2022-10-05 | LOW |
Public Mutual Berhad | Investment Advisor | 0.2371 | 4465000 | -4408000 | 2022-09-30 | LOW |
J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 0.2344 | 4413900 | -31400 | 2023-01-31 | MED |
1832 Asset Management L.P. | Investment Advisor | 0.2281 | 4294600 | 0 | 2023-01-31 | LOW |
Manulife Investment Management (North America) Limited | Investment Advisor | 0.2126 | 4002300 | -68800 | 2023-04-30 | LOW |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group535K+
Trader
87K+
Klien aktif per bulan
$113M+
Volume investasi per bulan
$64M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Industry: | Ambulance & Emergency Services |
585 North Bridge Road
#11-00 Raffles Hospital
188770
SG
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com